1. Christopher J. LaFargue, Paola Amero, Kyunghee Noh1, Lingegowda S. Mangala, Yunfei Wen, Emine Bayraktar , Sujanitha Umamaheswaran, Elaine Stur, Santosh K. Dasari, Cristina Ivan, Sunila Pradeep , Wonbeak Yoo, Chunhua Lu, Nicholas B. Jennings, Vinod Vathipadiekal, Wei Hu, Anca Chelariu-Raicu, Zhiqiang Ku, Hui Deng, Wei Xiong, Hyun-Jin Choi, Min Hu, Takae Kiyama1, Chai-An Mao, Rouba Ali-Fehmi, Michael J. Birrer, Jinsong Liu, Ningyan Zhang, Gabriel Lopez-Berestein, Vittorio de Franciscis, Zhiqiang An & Anil K. Sood “Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L” Nat Commun. 2023 Apr 26;14(1):2407. doi: 10.1038/s41467-023-36910-5.
2. Sung-Ho Park, Eun Sil Lee, Sung Taek Park, Soo Young Jeong, Yeoul Yun, YongGyeong Kim, Yulah Jeong, Chang-Ho Kang and Hyun Jin Choi “Efficacy and Safety of MED-01 Probiotics on Vaginal Health: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial” Nutrients 2023, 15, 331. https://doi.org/10.3390/nu15020331
3. Kyunghee Noh, Duc-Hiep Bach, Hyun-Jin Choi, Mark S. Kim, Sherry Y. Wu, Sunila Pradeep, Cristina Ivan, Min-Soon Cho, Emine Bayraktar, Cristian Rodriguez-Aguayo, Santosh K. Dasari, Elaine Stur, Lingegowda S. Mangala, Gabriel Lopez-Berestein & Anil K. Sood “The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis” Oncogene. 2021 Jan;40(2):384-395.doi: 10.1038/s41388-020-01517-3
4. Hyun Jin Choi , Myeong Seon Kim , Tae-Joong Kim “Uterine Artery Ligation at Its Origin Following Retroperitoneal Space Development Decreases Blood Loss During Single-Port Total Laparoscopic Hysterectomy” Taiwan J Obstet Gynecol . 2020 Mar;59(2):262-268.
5. Hyun Jin Choi, Gwang Jun Kim “ A giant symptomatic placental chorioangioma managed with a histoacryl injection” Journal of Ultrasound. 2020 May.
6. Choi HJ, Lee YY, Sohn I, Kim YM, Kim JW, Kang S, Kim BG “Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study." Curr Probl Cancer. 2020 Apr;44(2)
7. Choi HJ, Lee YY, Choi CH, Kim TJ, Lee JW, Bae JH, Bae DS, Kim BG “Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer." Curr Probl Cancer. 2020 Feb 12:
8. Hyun-Jin Choi, E sun Paik, Chel Hun Choi, Tae-Joong Kim, Yoo-Young Lee, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim “Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinumfor Patients With Metastatic, Recurrent, or PersistentCarcinoma of the Uterine Cervix; A Retrospective Analysis” Int J Gynecol Cancer 2018;28. 2018 Sep
9. Yung-Taek Ouh, HyunWoong Cho, Jae Kwan Lee, Song Hee Choi, Hyun Jin Choi, Jin Hwa Hong “CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer” Tumour Biol. 42(4) 2019 Apr
10. Se Hyun Nam, Hyun-Jin Choi, Woo Dae Kang, Seok Mo Kim, Myong cheol Lim, Sang-Yoon Park, Jung-Sup Kim, Byoung-Gie Kim, Duk-Soo Bae, Jeong-Won Lee, Tae-Joong Kim, Tae-jong Song “Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K)” Journal of Korean Medical Science 31(12) December 2016
11. Hyun-Jin Choi, Sunyoung Lee, Byung Kwan Park, Tae-Joong Kim, Chan Kyo Kim, Jung Jae Park, Chel Hun Choi, Yoo-Young Lee, Jeong-Won Lee, Duk-Soo Bae, and Byoung-Gie Kim “Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer” Journal of Gynecologic Oncology 27(4) · April 2016
12. Hyun Jin Choi, Tae-Joong Kim, Yoo-Young Lee, Jeong-Won Lee, Byoung-Gie Kim, and Duk-Soo Bae “Time-lapse imaging of sentinel lymph node using indocyanine green with near-infrared fluorescence imaging in early endometrial cancer” J Gynecol Oncol. 2016 May; 27(3): e27.
13. Hyun-Jin Choi,Eun Jin Heo, Esun Paik,Tae-Joong Kim,”Laparo-endoscopic single site paraaortic lymphadenectomy facilitated by a new articulating vessel sealing device” Gynecol Oncol. 2015 Nov;139(2):385-6
14. Paik ES, Choi HJ, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH.” Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer.” Cancer Res Treat. 2017 May 22.
15. Paik ES, Shim M, Choi HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH.” Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.” Gynecol Oncol. 2016 Nov;143(2):252-257.
16. Paik ES, Sohn I, Baek SY, Shim M, Choi HJ, Kim TJ, Choi CH, Lee JW, Kim BG, Lee YY, Bae DS. “Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.” Cancer Res Treat. 2017 Jul;49(3):635-642.
17. Paik ES, Lee YY, Shim M, Choi HJ, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.” Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery.” Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647.
18. Paik ES, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS. ” Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer.” Cancer Biomark. 2016;17(4):419-425.
19. Mangala LS, Wang H, Jiang D, Wu SY, Somasunderam A, Volk DE, Lokesh GL, Li X, Pradeep S, Yang X, Haemmerle M, Rodriguez-Aguayo C, Nagaraja AS, Rupaimoole R, Bayraktar E, Bayraktar R, Li L, Tanaka T, Hu W, Ivan C, Gharpure KM, McGuire MH, Thiviyanathan V, Zhang X, Maiti SN, Bulayeva N, Choi HJ, Dorniak PL, Cooper LJ, Rosenblatt KP, Lopez-Berestein G, Gorenstein DG, Sood AK. “ Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.” JCI Insight. 2016 Oct 20;1(17):e87754
20. Haemmerle M, Bottsford-Miller J, Pradeep S, Taylor ML, Choi HJ, Hansen JM, Dalton HJ, Stone RL, Cho MS, Nick AM, Nagaraja AS, Gutschner T, Gharpure KM, Mangala LS, Rupaimoole R, Han HD, Zand B, Armaiz-Pena GN, Wu SY, Pecot CV, Burns AR, Lopez-Berestein G, Afshar-Kharghan V, Sood AK. “FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal” J Clin Invest. 2016 May 2;126(5):1885-96.
21. Cho MS, Rupaimoole R, Choi HJ, Noh K, Chen J, Hu Q, Sood AK, Afshar-Kharghan V.”Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition” J Immunol. 2016 Feb 1;196(3):1412-8.
22. Kim SJ, Lee HJ, Kim SW, Choi HJ, He J, Wu Q, Aldape KD, Weinberg JS, Yung WK, Conrad CA, Langley RR, Lehembre F,Regenass U, Fidler IJ. “Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice” Clin Cancer Res. 2015 Jun 23
23. Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V. “Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.” PLoS One. 2015 Jun 22;10(6):e0131095
24. Bottsford-Miller J, Choi HJ, Dalton HJ, Stone RL, Cho MS, Haemmerle M, Nick AM, Pradeep S, Zand B, Previs RA, Pecot CV,Crane EK, Hu W, Lutgendorf SK, Afshar-Kharghan V, Sood AK. “Differential platelet levels affect response to taxane-based therapy in ovarian cancer.” Clin Cancer Res. 2015 Feb 1;21(3):602-10.
25. Choi HJ, Armaiz Pena GN, Pradeep S, Cho MS, Coleman RL, Sood AK. “Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches” Cancer Metastasis Rev. 2015 Mar;34(1):19-40
26. Kim SW, Choi HJ, Lee HJ, He J, Wu Q, Langley RR, Fidler IJ, Kim SJ. “Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells.” Neuro Oncol. 2014 Dec;16(12):1585-98.
27. Wu SY, Yang X, Gharpure KM, Hatakeyama H, Egli M, McGuire MH, Nagaraja AS, Miyake TM, Rupaimoole R, Pecot CV, Taylor M, Pradeep S, Sierant M, Rodriguez-Aguayo C, Choi HJ, Previs RA, Armaiz-Pena GN, Huang L, Martinez C, Hassell T, Ivan C, Sehgal V, Singhania R, Han HD, Su C, Kim JH, Dalton HJ, Kovvali C, Keyomarsi K, McMillan NA, Overwijk WW, Liu J,Lee JS, Baggerly KA, Lopez-Berestein G, Ram PT, Nawrot B, Sood AK “ 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.” Nat Commun. 2014 Mar 12;5:3459.
28. Cho MS, Vasquez HG, Rupaimoole R, Pradeep S, Wu S, Zand B, Han HD, Rodriguez-Aguayo C, Bottsford-Miller J, Huang J,Miyake T, Choi HJ, Dalton HJ, Ivan C, Baggerly K, Lopez-Berestein G, Sood AK, Afshar-Kharghan V. “Autocrine Effects of Tumor-Derived Complement Cell” Rep. 2014 Mar 27;6(6):1085-95.
29. Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, Pecot CV, Kim SJ, Choi HJ, Bischoff FZ, Mayer JA, Huang L, Nick AM Hall CS, Rodriguez-Aguayo C, Zand B, Dalton HJ, Arumugam T, Lee HJ, Han HD, Cho MS, Rupaimoole R, Mangala LS, Sehgal V, Oh SC, Liu J, Lee JS, Coleman RL, Ram P, Lopez-Berestein G, Fidler IJ, Sood AK. “Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread Cancer” Cell. 2014 Jul 14;26(1):77-91.
30. Han C, Liu Y, Wan G, Choi HJ, Zhao L, Ivan C, He X, Sood AK, Zhang X, Lu X “The RNA-Binding Protein DDX1 Promotes Primary MicroRNA Maturation and Inhibits Ovarian Tumor Progression” Cell Rep. 2014 Sep 11;8(5):1447-60.
31. Liu T, Hu W, Dalton HJ, Choi HJ, Huang J, Kang Y, Pradeep S, Miyake T, Song JH, Wen Y, Lu C, Pecot CV, Bottsford-Miller J, Zand B,Jennings NB, Ivan C, Gallick GE, Baggerly KA, Hangauer DG, Coleman RL, Frumovitz M, Sood AK. “Targeting Src and tubulin in mucinous ovarian carcinoma” Clin Cancer Res. 2013 Dec 1;19(23):6532-43
32. Kim SW, Kim JS, Papadopoulos J, Choi HJ, He J, Maya M, Langley RR, Fan D, Fidler IJ, Kim SJ. “Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse.” Int Immunopharmacol. 2011 Jul;11(7):862-72.
33. Choi HJ, Choi CH, Kim TJ, Kang HS, Lee EJ, Lee JW, Kim BG, Lee JH, Bae DS(2008)”A case of metachronous multiple primary malignant neoplasm of the gastric cancer and ovarian cancer and breast cancer.” Korean J of Obstet Gynecol.50: 1519-24
34. Cha HH, Choi HJ, Yoon JY, Song SE, Seo ES, Roh JR, Choi SJ, Kim JH(2009)” Interpregnancy interval after a previous preterm birth and subsequent preterm birth risk.” Korean J Obstet Gynecol 52:1109-16
35. Lee DY, Choi HJ, Choi DS, Min YK, Choe YH, Yoon BK” Impact of Medroxyprogesterone Acetate by Type of Combined Oral Estrogen on Mammographic Density in Korean Postmenopausal Women.(2010)” J Korean Soc Menopause 16:79-85. Korean
36. Kwak HM, Choi HJ, Cha HH, Yu HJ, Lee JH, Choi SJ, Oh SY, Roh CR, Kim JH.(2012)”Amniopatch Treatment for Spontaneous Previable, Preterm Premature Rupture of Membranes Associated or Not with Incompetent Cervix” Fetal Diagn Thera.: Fetal Diagn Ther. 2013;33(1):47-54.